106
Views
3
CrossRef citations to date
0
Altmetric
Research Article

Association between Alzheimer's disease and the NOS3 gene Glu298Asp polymorphism

, , &
Pages 243-251 | Received 23 May 2013, Accepted 09 Aug 2013, Published online: 23 Sep 2013

References

  • Corder EH, Saunders AM, Strittmatter WJ, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993;261:921–3.
  • Dinerman JL, Dawson TM, Schell MJ, Endothelial nitric oxide synthase localized to hippocampal pyramidal cells: implications for synaptic plasticity. Proc Natl Acad Sci USA 1994;91:4214–8.
  • Marsden PA, Heng HH, Scherer SW, Structure and chromosomal localization of the human constitutive endothelial nitric oxide synthase gene. J Biol Chem 1993;268:17478–88.
  • Dahiyat M, Cumming A, Harrington C, Association between Alzheimer's disease and the NOS3 gene. Ann Neurol 1999;46:664–7.
  • Crawford F, Freeman M, Abdullah L, No association between the NOS3 codon 298 polymorphism and Alzheimer's disease in a sample from the United States. Ann Neurol 2000;47:687.
  • Higuchi S, Ohta S, Matsushita BS, NOS3 polymorphism not associated with Alzheimer's disease in Japanese. Ann Neurol 2000;48:685.
  • Kunugi H, Akahane A, Ueki A, No evidence for an association between the Glu298Asp polymorphism of the NOS3 gene and Alzheimer's disease. J Neural Transm 2000;107: 1081–4.
  • McKhann G, Drachman D, Folstein M, Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 1984;34:939–944.
  • Egger M, Davey SG, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315:629-634.
  • Akomolafe A, Lunetta KL, Erlich PM, MIRAGE Study Group. Genetic association between endothelial nitric oxide synthase and Alzheimer disease. Clin Genet 2006;70:49–56.
  • Blomqvist ME, Reynolds C, Katzov H, et al. Towards compendia of negative genetic association studies: an example for Alzheimer disease. Hum Genet 2006;119:29–37.
  • Dahiyat M, Cumming A, Harrington C, Association between Alzheimer's disease and the NOS3 gene. Ann Neurol 1999;46:664–667.
  • Emahazion T, Feuk L, Jobs M, SNP association studies in Alzheimer's disease highlight problems for complex disease analysis. Trends Genet 2001;17:407–413.
  • Giedraitis V, Kilander L, Degerman-Gunnarsson M, Genetic analysis of Alzheimer's disease in the Uppsala Longitudinal Study of Adult Men. Dement Geriatr Cogn Disord 2009;27:59–68.
  • Guidi I, Galimberti D, Venturelli E, Influence of the Glu298Asp polymorphism of NOS3 on age at onset and homocysteine levels in AD patients. Neurobiol Aging 2005;26:789–794.
  • Kalman J, Juhasz A, Rimanoczy A, The nitric oxide synthase-3 codon 298 polymorphism is not associated with late-onset sporadic Alzheimer's dementia and Lewy body disease in a sample from Hungary. Psychiatr Genet 2003;13:201–204.
  • Li H, Wetten S, Li L, St Jean PL, Candidate single-nucleotide polymorphisms from a genomewide association study of Alzheimer disease. Arch Neurol 2008;65:45–53.
  • Monastero R, Cefalu AB, Camarda C, No association between Glu298Asp endothelial nitric oxide synthase polymorphism and Italian sporadic Alzheimer's disease. Neurosci Lett 2003;341:229–232.
  • Sanchez-Guerra M, Combarros O, Alvarez-Arcaya A, The Glu298Asp polymorphism in the NOS3 gene is not associated with sporadic Alzheimer's disease. J Neurol Neurosurg Psychiatry 2001;70:566–567.
  • Singleton AB, Gibson AM, McKeith IG, Nitric oxide synthase gene polymorphisms in Alzheimer's disease and dementia with Lewy bodies. Neurosci Lett 2001;303:33–36.
  • Styczynska M, Religa D, Pfeffer A, et al. Simultaneous analysis of five genetic risk factors in Polish patients with Alzheimer's disease. Neurosci Lett 2003;344:99–102.
  • Tedde A, Nacmias B, Cellini E, Lack of association between NOS3 polymorphism and Italian sporadic and familial Alzheimer's disease. J Neurol 2002;249:110–111.
  • Wang B, Tan S, Yang Z, Association between Alzheimer's disease and the NOS3 gene Glu298Asp polymorphism in Chinese. J Mol Neurosci 2008;34:173–176.
  • Yang Z, Li S, Jing F, Association between Alzheimer's disease and the NOS3 gene Glu298Asp polymorphism. Chinese J Geriatr 2004;7:468–471.
  • Zhou YT, Zhang ZX, Zhang JW, Association between NOS3 polymorphism and Alzheimer's disease in Chinese Han population. Chinese J Clin Neurosci 2006;14: 246–250.
  • Galbusera, C, Facheris, M, Magni, F, Increased susceptibility to plasma lipid peroxidation in Alzheimer disease patients. Curr Alzheimer Res 2004;1:103–109.
  • Wang XL, Mahaney MC, Sim AS, Genetic contribution of the endothelial constitutive nitric oxide synthase gene to plasma nitric oxide levels. Arterioscler Thromb Vasc Biol 1997;17:3147–3153.
  • Yoshimura M, Yasue H, Nakayama M, A missense glu298asp variant in the endothelial nitric oxide synthase gene is associated with coronary spasm in the Japanese. Human Gen 1998;103:65–69.
  • Veldman BA, Spiering W, Doevendans PA, The Glu298Asp polymorphism of the NOS3 gene as a determinant of the baseline production of nitric oxide. J Hypertens 2002;20:2023–2027.
  • Wang XL, Sim AS, Wang MX, Genotype dependent and cigarette specific effects on endothelial nitric oxide synthase gene expression and enzyme activity. FEBS Lett 2000;471:45–50.
  • Du Y, Dodel RC, Eastwood BJ, Association of an interleukin 1 alpha polymorphism with Alzheimer's disease. Neurology 2000;55:480–483.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.